These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

482 related items for PubMed ID: 9339198

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Primary ovarian sarcoma: analysis of prognostic variables and the role of surgical cytoreduction.
    Sood AK, Sorosky JI, Gelder MS, Buller RE, Anderson B, Wilkinson EJ, Benda JA, Morgan LS.
    Cancer; 1998 May 01; 82(9):1731-7. PubMed ID: 9576296
    [Abstract] [Full Text] [Related]

  • 3. Serum CA-125 level after 6 cycles of primary adjuvant chemotherapy is a useful prognostic factor for complete responders' survival in patients with advanced epithelial ovarian cancer.
    Kim HS, Park NH, Chung HH, Kim JW, Song YS, Kang SB.
    Onkologie; 2008 Jun 01; 31(6):315-20. PubMed ID: 18547972
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Prognostic value of serum CA(125) level change during chemotherapy post-surgery in patients with advanced epithelial ovarian carcinoma].
    Lan CY, Huang H, Liu JH.
    Zhonghua Fu Chan Ke Za Zhi; 2008 Oct 01; 43(10):732-6. PubMed ID: 19087537
    [Abstract] [Full Text] [Related]

  • 7. CA125 level as a predictor of progression-free survival and overall survival in ovarian cancer patients with surgically defined disease status prior to the initiation of intraperitoneal consolidation therapy.
    Juretzka MM, Barakat RR, Chi DS, Iasonos A, Dupont J, Abu-Rustum NR, Poynor EA, Aghajanian C, Spriggs D, Hensley ML, Sabbatini P.
    Gynecol Oncol; 2007 Jan 01; 104(1):176-80. PubMed ID: 16996584
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The predictive and prognostic value of serum CA 125 half-life during paclitaxel/platinum-based chemotherapy in patients with advanced ovarian carcinoma.
    Gadducci A, Cosio S, Fanucchi A, Negri S, Cristofani R, Genazzani AR.
    Gynecol Oncol; 2004 Apr 01; 93(1):131-6. PubMed ID: 15047226
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Prognostic value of Ca 125 levels during primary therapy.
    Markmann S, Gerber B, Briese V.
    Anticancer Res; 2007 Apr 01; 27(4A):1837-9. PubMed ID: 17649781
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Survival impact of surgical cytoreduction in stage IV epithelial ovarian cancer.
    Bristow RE, Montz FJ, Lagasse LD, Leuchter RS, Karlan BY.
    Gynecol Oncol; 1999 Mar 01; 72(3):278-87. PubMed ID: 10053096
    [Abstract] [Full Text] [Related]

  • 19. CA-125 AUC as a new prognostic factor for patients with ovarian cancer.
    Mano A, Falcão A, Godinho I, Santos J, Leitão F, Oliveira C, Caramona M.
    Gynecol Oncol; 2005 May 01; 97(2):529-34. PubMed ID: 15863156
    [Abstract] [Full Text] [Related]

  • 20. Analysis of treatment failures and survival of patients with fallopian tube carcinoma: a cooperation task force (CTF) study.
    Gadducci A, Landoni F, Sartori E, Maggino T, Zola P, Gabriele A, Rossi R, Cosio S, Fanucchi A, Tisi G.
    Gynecol Oncol; 2001 May 01; 81(2):150-9. PubMed ID: 11330942
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.